221 related articles for article (PubMed ID: 16189518)
21. [Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].
Matsui K; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Takii Y; Tsuchiya Y; Tanaka O
Gan To Kagaku Ryoho; 2009 Jun; 36(6):953-7. PubMed ID: 19542714
[TBL] [Abstract][Full Text] [Related]
22. Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer.
Furusaka T; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2011 Oct; 131(10):1099-103. PubMed ID: 21651316
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
Suzuki S; Ishikawa K
J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
[TBL] [Abstract][Full Text] [Related]
24. How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?
Hirai M; Orita Y; Takao S; Tachibana T; Marunaka H; Makihara S; Miki K; Noyama Y; Fuji S; Torigoe A; Sato Y; Nishizaki K
Acta Otolaryngol; 2015; 135(10):1079-85. PubMed ID: 26004393
[TBL] [Abstract][Full Text] [Related]
25. [Examination of the feasibility of TS-1 for postoperative advance stomach cancer patients].
Hara A; Tokuhara T; Takahashi Y; Izumi N; Iwamoto S; Satake K
Gan To Kagaku Ryoho; 2004 Apr; 31(4):601-4. PubMed ID: 15114708
[TBL] [Abstract][Full Text] [Related]
26. [Adjuvant chemotherapy with S-1 for head and neck carcinoma].
Terao K; Saito K; Mori K; Murata K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):425-9. PubMed ID: 18347390
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S; Sasako M; Yamaguchi T; Kinoshita T; Fujii M; Nashimoto A; Furukawa H; Nakajima T; Ohashi Y; Imamura H; Higashino M; Yamamura Y; Kurita A; Arai K;
N Engl J Med; 2007 Nov; 357(18):1810-20. PubMed ID: 17978289
[TBL] [Abstract][Full Text] [Related]
28. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
[TBL] [Abstract][Full Text] [Related]
29. [Adverse reactions to TS-1 for outpatients with recurrent head and neck cancer].
Nishino H; Shinozaki T; Ishikawa K; Tanaka H; Ichimura K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):2019-23. PubMed ID: 12465408
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
Nakamura M; Koga M; Aoki M; Iwamoto O; Koga C; Kusukawa J
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1841-3. PubMed ID: 22083193
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
[TBL] [Abstract][Full Text] [Related]
32. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
[TBL] [Abstract][Full Text] [Related]
33. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
[TBL] [Abstract][Full Text] [Related]
34. [A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Kajikawa H; Nario K; Miyahara H
Gan To Kagaku Ryoho; 2004 Apr; 31(4):631-4. PubMed ID: 15114715
[TBL] [Abstract][Full Text] [Related]
35. [Radiotherapy in combination with low-dose chemotherapy in locally advanced head and neck cancer].
Nagy B; Molnár J; Rovó L; Paczona R; Thurzó L
Magy Onkol; 2004; 48(2):145-9. PubMed ID: 15351810
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
37. [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1].
Yamamoto K; Obara S; Mishima K; Nakamura H; Yoshimura Y
Gan To Kagaku Ryoho; 2004 Apr; 31(4):635-7. PubMed ID: 15114716
[TBL] [Abstract][Full Text] [Related]
38. [Results of chemotherapy in head and neck cancer patients with residual or recurrent tumors after initial treatment].
Katsuno M; Watanabe N; Sugio Y; Tachibana S; Tani Y; Sato N; Zusho H
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2109-13. PubMed ID: 21084809
[TBL] [Abstract][Full Text] [Related]
39. [Indication of alternate-day treatment with S-1 in patients with oral cancer].
Negishi A; Ogawa M; Kosugi K; Takayama Y; Gomi A; Miyazaki H; Yokoo S
Gan To Kagaku Ryoho; 2015 May; 42(5):569-73. PubMed ID: 25981649
[TBL] [Abstract][Full Text] [Related]
40. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]